Tm Bioscience Gains $5.6M in Private Debt, Stock Placement | GenomeWeb
NEW YORK (GenomeWeb News) — Tm Bioscience said yesterday that it has completed a private placement of unsecured subordinated debt and common share purchase warrants worth CA$6.24 million ($5.6 million)
The placement comes one day after the firm announced its second quarter financial results.  
Tm said it will use the proceeds to develop genetic tests and for general working capital purposes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.